The inside story of the DEA battle with lawyers John Hunter and Matt Zorn

The legal conflict between the DEA and advocates seeking to prevent the scheduling of tryptamines highlights the complexities of drug policy. Lawyers John Hunter and Matt Zorn discuss the procedural battle and the DEA's evidence collection methods, noting that while the agency successfully delayed certain research, they ultimately failed to secure prohibition for all substances in question. The interview highlights that although the DEA demonstrated significant power to obstruct research, they were unable to overcome the robust evidence base supporting the therapeutic validity of the substances. This legal precedent provides insight into the bureaucratic hurdles researchers face, yet the partial victory suggests a promising shift in the balance of power, encouraging ongoing scientific engagement with these psychedelic compounds.